Look behind the lecture: Patient-reported outcomes in cancer trials
In this interview, Jessica Roydhouse, of the FDA (MD, USA), discusses her presentation from ISPOR (18—22 May, New Orleans, LA, USA) on the impact of patient-reported outcomes on the design and analysis of cancer clinical trials.
Please sign in or register for FREE
Sign in to The Evidence Base
Did you know?
Your The Evidence Base™ account also gives you access to communities on regenerative medicine, real-world evidence and drug discovery. Find out more>>